586 Stathmin
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Benzenoids | 1 | 0.1 | 6.94× | not tested | |
| Organoheterocyclic compounds | 1 | 0.3 | 3.29× | not tested | |
| Organic acids and derivatives | 1 | 0.3 | 3.28× | not tested | |
| Homogeneous metal compounds | 2 | 1.0 | 2.07× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01206 | — | — | 1 |
| DB07574 | — | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 110 |
| A1L2T | ~{N}4-(1,3-benzodioxol-5-ylmethyl)-6-(1~{H}-indol-4-yl)pyrimidine-2,4-diamine | 1 |
| LVV | 4-[(4-methylphenyl)methyl]-1,4-thiazinane 1,1-dioxide | 1 |
| NUY | [4-(propan-2-yl)piperazin-1-yl](thiophen-2-yl)methanone | 1 |
| UR1 | 3-fluoro-5-methylbenzene-1-sulfonamide | 1 |
| WZP | 2-methyl-1-[4-(propan-2-yl)piperazin-1-yl]propan-1-one | 1 |
| WZY | N-(4-methoxyphenyl)glycinamide | 1 |
| X1M | 1-(6-methoxypyridin-2-yl)-N-methylmethanamine | 1 |